We aren’t the first to note the latest class action denial in the prescription medical product liability field, In re Panacryl Sutures Products Liability Cases, No. 5:08-MD-1959-BO, slip op. (E.D.N.C. Nov. 13, 2009). 360 (subscription only) beat us to the punch the other day. But just because we aren’t first, doesn’t mean there’s nothing in Panacryl worth blogging about. We view decisions like...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Latest Class Action Decision Shows That The Battles Were Important
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account